In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...

Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues. We ...

As of February 20, 2025, its stock price has risen 17.8% year-to-date, outperforming the broader medical sector and key competitors like Abbott ... emerging field of pulsed field ablation ...

Broward Health is proud to be one of the first healthcare systems in Broward County to offer the FARAPULSE™ Pulsed Field Ablation System, a groundbreaking technology to treat atrial fibrillation ...

The EP system resolves these irregularities through a procedure called ablation, which targets and prevents heart tissues from emitting erratic electrical impulses, thereby normalizing the heart's ...

[Image from Brad Sutton on LinkedIn] Boston Scientific (NYSE: BSX) + today announced the completion of the first-ever cases with its Faraflex mapping and pulsed field ablation (PFA) catheter.

The company’s long-term investments in cutting-edge innovation, such as pulsed-field ablation, are beginning ... However, its key rivals like Abbott ABT and Boston Scientific BSX outperformed ...